Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Strategy Officer
-
Stock Symbol
-
ANTX on Nasdaq
Stephen David Prior - trading volume in the past year for AN2 Therapeutics, Inc.
Holdings reported by Stephen David Prior for AN2 Therapeutics, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
33.3K |
$44.7K |
$1.34 |
Jan 3, 2025 |
Direct |
|
|
| Stock Option (right to buy) |
20.3K |
|
|
Nov 4, 2024 |
Direct |
Common Stock |
|
Transactions reported by Stephen David Prior for AN2 Therapeutics, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.